Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Schentag

Showing results (61-70 of 236) with videos related to

Pageof 24
Sort By:
Journal of Pharmaceutical Sciences|July 1, 1994
Pharmacodynamic modeling of bacterial kinetics: beta-lactam antibiotics against Escherichia coliR C Li, D E Nix, J J Schentag
Pharmaceutical Research|June 1, 1994
Interaction between ciprofloxacin and metal cations: its influence on physicochemical characteristics and antibacterial activityR C Li, D E Nix, J J Schentag
The New England Journal of Medicine|September 27, 1984
No false "Hemoccult" reaction with ranitidineJ M DeVito, D E Nix, J J Schentag
The Journal of Antimicrobial Chemotherapy|July 1, 1984
Cefmenoxime in the treatment of nosocomial pneumonias in critical care patientsD P Reitberg, T J Cumbo, J J Schentag
Antimicrobial Agents and Chemotherapy|February 1, 1984
Pharmacokinetics of ceftazidime in patients with renal insufficiencyL S Welage, R W Schultz, J J Schentag
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1984
The partitioning of cimetidine into canine cerebrospinal fluidJ A Ziemniak, R G Shank, J J Schentag
The Journal of Antimicrobial Chemotherapy|January 1, 1985
Dual individualization: antibiotic dosage calculation from the integration of in-vitro pharmacodynamics and in-vivo pharmacokineticsJ J Schentag, D J Swanson, I L Smith
Journal of Chemotherapy (Florence, Italy)|February 1, 1996
Performance of the fractional maximal effect method: comparative interaction studies of ciprofloxacin and protein synthesis inhibitorsR C Li, D E Nix, J J Schentag
Journal of Pharmaceutical Sciences|July 1, 1984
Pharmacokinetics of capacity-limited tissue distribution of methicillin in rabbitsF M Gengo, J J Schentag, W J Jusko
Pharmacoeconomics|November 3, 1996
The economic potential of dual individualisation methodologiesJ A Paladino, G S Zimmer, J J Schentag
Pageof 24

Showing results (61-70 of 236) with videos related to

Sort By:
Pageof 24
Journal of Pharmaceutical Sciences|July 1, 1994
Pharmacodynamic modeling of bacterial kinetics: beta-lactam antibiotics against Escherichia coliR C Li, D E Nix, J J Schentag
Pharmaceutical Research|June 1, 1994
Interaction between ciprofloxacin and metal cations: its influence on physicochemical characteristics and antibacterial activityR C Li, D E Nix, J J Schentag
The New England Journal of Medicine|September 27, 1984
No false "Hemoccult" reaction with ranitidineJ M DeVito, D E Nix, J J Schentag
The Journal of Antimicrobial Chemotherapy|July 1, 1984
Cefmenoxime in the treatment of nosocomial pneumonias in critical care patientsD P Reitberg, T J Cumbo, J J Schentag
Antimicrobial Agents and Chemotherapy|February 1, 1984
Pharmacokinetics of ceftazidime in patients with renal insufficiencyL S Welage, R W Schultz, J J Schentag
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1984
The partitioning of cimetidine into canine cerebrospinal fluidJ A Ziemniak, R G Shank, J J Schentag
The Journal of Antimicrobial Chemotherapy|January 1, 1985
Dual individualization: antibiotic dosage calculation from the integration of in-vitro pharmacodynamics and in-vivo pharmacokineticsJ J Schentag, D J Swanson, I L Smith
Journal of Chemotherapy (Florence, Italy)|February 1, 1996
Performance of the fractional maximal effect method: comparative interaction studies of ciprofloxacin and protein synthesis inhibitorsR C Li, D E Nix, J J Schentag
Journal of Pharmaceutical Sciences|July 1, 1984
Pharmacokinetics of capacity-limited tissue distribution of methicillin in rabbitsF M Gengo, J J Schentag, W J Jusko
Pharmacoeconomics|November 3, 1996
The economic potential of dual individualisation methodologiesJ A Paladino, G S Zimmer, J J Schentag
Pageof 24